Literature DB >> 22237484

Effects of antidepressants and cyclooxygenase-2 inhibitor on cytokines and kynurenines in stimulated in vitro blood culture from depressed patients.

Daniela L Krause1, Michael Riedel, Norbert Müller, Elif Weidinger, Markus J Schwarz, Aye-Mu Myint.   

Abstract

BACKGROUND: Immune activation induces a pro-inflammatory state, which enhances the tryptophan degradation into kynurenine (KYN). The involvement of kynurenines has been shown in patients with major depression. Here, the effects of anti-inflammatory medication and antidepressants on cytokines and tryptophan metabolite changes in blood culture with immune challenge [bacterial mimetic lipopolysaccharide (LPS)] were investigated.
MATERIALS AND METHODS: A total of 21 depressed patients and 38 matched controls were recruited. Whole blood cultures were stimulated with LPS and drugs were added (celecoxib, venlafaxine, reboxetine, imipramine and fluoxetine). Cytokines and kynurenines were analysed.
RESULTS: After stimulation with LPS, the interferon-γ and interleukin (IL)-10 secretions were significantly higher in controls than in patients (p = 0.045, p = 0.032), respectively. Adding imipramine and celecoxib abolished the significance for IL-10. Challenge with LPS induced the kynurenine pathway in each group. Regarding the ratio KYNA/KYN, which indicated how much of KYN formed is further catabolised into the neuroprotective arm, the controls' blood cultures showed a significantly higher ratio (p = 0.045). DISCUSSION: Stimulation with LPS induced increased production of pro-inflammatory and anti-inflammatory cytokines in both groups, but higher responses in controls. This lower production of cytokine responses in depressed patients indicates that their immune cells are in a refractory phase, induced by a pre-existing pro-inflammatory state. For kynurenines, the whole metabolism was enhanced by LPS; however, an imbalance to neuroprotective metabolites was observed just in control blood. A drug effect could only be shown for imipramine and celecoxib, which were beneficial in terms of re-balancing the immune function but not in re-balancing neuroactive metabolites.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22237484     DOI: 10.1007/s10787-011-0112-6

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  27 in total

Review 1.  How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli.

Authors:  S Rivest; S Lacroix; L Vallières; S Nadeau; J Zhang; N Laflamme
Journal:  Proc Soc Exp Biol Med       Date:  2000-01

2.  Quinolinate neurotoxicity in cortical cell culture.

Authors:  J P Kim; D W Choi
Journal:  Neuroscience       Date:  1987-11       Impact factor: 3.590

3.  Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration.

Authors:  Daniel Zwilling; Shao-Yi Huang; Korrapati V Sathyasaikumar; Francesca M Notarangelo; Paolo Guidetti; Hui-Qiu Wu; Jason Lee; Jennifer Truong; Yaisa Andrews-Zwilling; Eric W Hsieh; Jamie Y Louie; Tiffany Wu; Kimberly Scearce-Levie; Christina Patrick; Anthony Adame; Flaviano Giorgini; Saliha Moussaoui; Grit Laue; Arash Rassoulpour; Gunnar Flik; Yadong Huang; Joseph M Muchowski; Eliezer Masliah; Robert Schwarcz; Paul J Muchowski
Journal:  Cell       Date:  2011-06-10       Impact factor: 41.582

4.  Diagnostic and statistical manual of mental disorders, 3rd ed. (DSM-III), adaptive functioning in young Swedish suicides.

Authors:  B S Runeson; C L Rich
Journal:  Ann Clin Psychiatry       Date:  1994-09       Impact factor: 1.567

5.  Kynurenine pathway in major depression: evidence of impaired neuroprotection.

Authors:  Aye-Mu Myint; Yong Ku Kim; Robert Verkerk; Simon Scharpé; Harry Steinbusch; Brian Leonard
Journal:  J Affect Disord       Date:  2006-09-06       Impact factor: 4.839

6.  IFN-gamma reduction by tricyclic antidepressants.

Authors:  Hubertus Himmerich; Stephany Fulda; Abigail J Sheldrick; Birgit Plümäkers; Lothar Rink
Journal:  Int J Psychiatry Med       Date:  2010       Impact factor: 1.210

7.  Cytokines and serotonin transporter in patients with major depression.

Authors:  Chiung-Wen Tsao; Yee-Shin Lin; Chwen-Cheng Chen; Chyi-Huey Bai; Shin-Rung Wu
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-03-06       Impact factor: 5.067

8.  A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.

Authors:  M P Heyes; K Saito; E O Major; S Milstien; S P Markey; J H Vickers
Journal:  Brain       Date:  1993-12       Impact factor: 13.501

9.  Inhibitory effects of amantadine on the production of pro-inflammatory cytokines by stimulated in vitro human blood.

Authors:  Marta Kubera; Michael Maes; Bogusława Budziszewska; Agnieszka Basta-Kaim; Monika Leśkiewicz; Beata Grygier; Zofia Rogóz; Władysław Lasoń
Journal:  Pharmacol Rep       Date:  2009 Nov-Dec       Impact factor: 3.024

10.  The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.

Authors:  N Müller; M J Schwarz; S Dehning; A Douhe; A Cerovecki; B Goldstein-Müller; I Spellmann; G Hetzel; K Maino; N Kleindienst; H-J Möller; V Arolt; M Riedel
Journal:  Mol Psychiatry       Date:  2006-02-21       Impact factor: 15.992

View more
  14 in total

Review 1.  Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?

Authors:  David Baumeister; Simone Ciufolini; Valeria Mondelli
Journal:  Psychopharmacology (Berl)       Date:  2015-08-14       Impact factor: 4.530

Review 2.  Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies.

Authors:  Gislaine Z Réus; Karen Jansen; Stephanie Titus; André F Carvalho; Vilma Gabbay; João Quevedo
Journal:  J Psychiatr Res       Date:  2015-05-19       Impact factor: 4.791

3.  Norepinephrine-enhancing antidepressant exposure associated with reduced antiviral effect of interferon alpha on hepatitis C.

Authors:  Renata Fialho; Alison Burridge; Marco Pereira; Majella Keller; Alexandra File; Jeremy Tibble; Richard Whale
Journal:  Psychopharmacology (Berl)       Date:  2015-05-15       Impact factor: 4.530

4.  Role of Kynurenine pathway and its metabolites in mood disorders: A systematic review and meta-analysis of clinical studies.

Authors:  Danilo Arnone; Smita Saraykar; Haitham Salem; Antonio L Teixeira; Robert Dantzer; Sudhakar Selvaraj
Journal:  Neurosci Biobehav Rev       Date:  2018-06-22       Impact factor: 8.989

5.  Gentiopicroside abrogates lipopolysaccharide-induced depressive-like behavior in mice through tryptophan-degrading pathway.

Authors:  Ya-Ting Deng; Ming-Gao Zhao; Tian-Jiao Xu; Xin-Hua Li
Journal:  Metab Brain Dis       Date:  2018-06-15       Impact factor: 3.584

6.  Distinct inflammatory response patterns are evident among men and women with higher depressive symptoms.

Authors:  Marzieh Majd; Jennifer E Graham-Engeland; Joshua M Smyth; Martin J Sliwinski; Richard B Lipton; Mindy J Katz; Christopher G Engeland
Journal:  Physiol Behav       Date:  2017-11-10

7.  Stress-induced impairment in fear discrimination is causally related to increased kynurenic acid formation in the prefrontal cortex.

Authors:  Alex D Klausing; Tsutomu Fukuwatari; David J Bucci; Robert Schwarcz
Journal:  Psychopharmacology (Berl)       Date:  2020-03-25       Impact factor: 4.530

8.  Modulation of cytokine production by drugs with antiepileptic or mood stabilizer properties in anti-CD3- and anti-Cd40-stimulated blood in vitro.

Authors:  Hubertus Himmerich; Stefanie Bartsch; Hajo Hamer; Roland Mergl; Jeremias Schönherr; Charlotte Petersein; Alexander Munzer; Kenneth Clifford Kirkby; Katrin Bauer; Ulrich Sack
Journal:  Oxid Med Cell Longev       Date:  2014-03-16       Impact factor: 6.543

9.  Monocytes from depressed patients display an altered pattern of response to endotoxin challenge.

Authors:  Lucia Lisi; Giovanni Camardese; Mariangela Treglia; Giuseppe Tringali; Cinzia Carrozza; Luigi Janiri; Cinzia Dello Russo; Pierluigi Navarra
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

10.  Unique immunologic patterns in fibromyalgia.

Authors:  Frederick G Behm; Igor M Gavin; Oleksiy Karpenko; Valerie Lindgren; Sujata Gaitonde; Peter A Gashkoff; Bruce S Gillis
Journal:  BMC Clin Pathol       Date:  2012-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.